Literature DB >> 27083961

Effects of Xuebijing injection on microcirculation in septic shock.

Liang Wang1, Zhiyong Liu1, Zhe Dong1, Jieyi Pan1, Xiaochun Ma2.   

Abstract

BACKGROUND: This study was conducted to investigate whether Xuebijing injection can rectify the dysfunction of microcirculation in septic shock and assessed the microcirculatory parameters directly via orthogonal polarization spectral and software AVA 3.0.
MATERIAL AND METHODS: Anesthetized and mechanically ventilated beagle dogs were modeled for septic shock via lipopolysaccharide (LPS) intravenous injection. They were divided randomly into four groups, control group accepted operation only for jejunostomy and cystostomy; LPS group accepted operation and LPS intravenous injection; saline group accepted operation, LPS intravenous injection, and saline resuscitation; XBJ group accepted operation, LPS intravenous injection, saline resuscitation, and Xuebijing injection infusion. The MAP was recorded via right femoral artery catheterization, at the same time, the blood gas analysis was taken via that pathway at the set time points. ScvO2 was obtained via right jugular vein catheterization at the related time points. Microcirculatory parameters were recorded by orthogonal polarization spectral via the jejunum stoma, and the microcirculation image was analyzed via the software AVA 3.0 later.
RESULTS: Xuebijing injection improved microcirculation of the jejunum villus in canine model of septic shock induced by endotoxin, especially for the proportion of perfused vessels.
CONCLUSIONS: Based on the adequate fluid resuscitation, Xuebijing injection plays a helpful role of improving microcirculation in septic shock.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Microcirculation; Sepsis; Xuebijing

Mesh:

Substances:

Year:  2015        PMID: 27083961     DOI: 10.1016/j.jss.2015.12.041

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  7 in total

1.  Intravenous injection of Xuebijing attenuates acute kidney injury in rats with paraquat intoxication.

Authors:  Jia-Jun Xu; Jian-Tao Zhen; Li Tang; Qing-Ming Lin
Journal:  World J Emerg Med       Date:  2017

2.  A Case-Control Study of Continuous Veno-Venous Hemofiltration Combined with Xuebijing Injection in the Treatment of Severe Sepsis.

Authors:  Yan Liu; Bing Wang; Qian Zhang; Yuliang Zhao; Xudong Wang
Journal:  Contrast Media Mol Imaging       Date:  2022-05-28       Impact factor: 3.009

3.  High degree of pharmacokinetic compatibility exists between the five-herb medicine XueBiJing and antibiotics comedicated in sepsis care.

Authors:  Jian Li; Olajide E Olaleye; Xuan Yu; Weiwei Jia; Junling Yang; Chuang Lu; Songqiao Liu; Jingjing Yu; Xiaona Duan; Yaya Wang; Kai Dong; Rongrong He; Chen Cheng; Chuan Li
Journal:  Acta Pharm Sin B       Date:  2019-06-19       Impact factor: 11.413

4.  Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines.

Authors:  Chuan Li; Wei-Wei Jia; Jun-Ling Yang; Chen Cheng; Olajide E Olaleye
Journal:  Acta Pharmacol Sin       Date:  2022-09-16       Impact factor: 7.169

5.  Weaker Response to XueBiJing Treatment in Severe Community-Acquired Pneumonia Patients With Higher Body Mass Index or Hyperglycemia: A Post Hoc Analysis of a Randomized Controlled Trial.

Authors:  Yansha Song; Xiaocen Wang; Cuicui Chen; Tingting Wei; Ke Lang; Dong Yang; Yuanlin Song
Journal:  Front Pharmacol       Date:  2022-06-03       Impact factor: 5.988

6.  Novel assays for quality evaluation of XueBiJing: Quality variability of a Chinese herbal injection for sepsis management.

Authors:  Xuan Yu; Wei Niu; Ya-Ya Wang; Olajide E Olaleye; Jia-Nan Wang; Meng-Yuan Duan; Jun-Ling Yang; Rong-Rong He; Zi-Xuan Chu; Kai Dong; Gui-Ping Zhang; Chang-Xiao Liu; Chen Cheng; Chuan Li
Journal:  J Pharm Anal       Date:  2022-01-26

7.  Xuebijing Injection Alleviates Pam3CSK4-Induced Inflammatory Response and Protects Mice From Sepsis Caused by Methicillin-Resistant Staphylococcus aureus.

Authors:  Tiantian Li; Yiming Qian; Zhulei Miao; Peiyong Zheng; Ting Shi; Xinru Jiang; Lingyun Pan; Fenghua Qian; Guizhen Yang; Huazhang An; Yuejuan Zheng
Journal:  Front Pharmacol       Date:  2020-02-21       Impact factor: 5.810

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.